By incorporating this additional criterion, the count of marker genes within the regulatory network exhibiting unidirectional expression alterations in both HCC patients and cell lines was reduced to four: ID1, FEN1, CDKN2A, and TERT. The gene discussed is CDKN2A; the disease is hepatocellular carcinoma.